So if they are in a medical centre does that mean 100% supply going forward or is it just a statement that they have actually bought a few patches of AHZ ? most of these centres mentioned in the report can still have potential 99% supply from a competitor with only small sales for AHZ as they are in " trialling phase" .... I wish we knew the uptake percentage per centre over time.. I guess if they switch over after trials it could go from 1% supply to immediately 100% overnight. This can occur to a lot of centres this quarter if they are in the final phases of approving wide use within its cardio surgery wards
What do you want from the Quarterly, page-15
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |